Hapoalim Securities Terminates Healthcare Coverage Including Bristol-Myers, Eli Lilly, Merck and Pfizer

Hapoalim Securities is terminating coverage of Bristol-Myers BMY, Eli Lilly LLY, Merck MRK, Pfizer PFE, Acorda ACOR, Alkermes ALKS, Amarin AMRN, Amylin AMLN, Arena Pharmaceuticals ARNA, Auxilium AUXL, Biospecifics BSTC, Cephalon CEPH, MannKind MNKD, Medivation MDVN, Nektar NKTR, Neurocrine Biosciences NBIX, Protalix PLX, Targacept TRGT and Vanda Pharmaceuticals VNDA due to an analyst departure.